Old Web
English
Sign In
Acemap
>
Paper
>
Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
2017
Tatyana I. Ionova
Nb Bulieva
OYu Vinogradova
Taras Gritsenko
Lk Kozlova
Galina B Kuchma
Elza Lomaia
Er Machyulaitene
T. Nikitina
Nv Novitskaya
AYu Rodionova
Elena Usacheva
Tatiana Shneider
Keywords:
Second-line therapy
Oncology
Myeloid leukemia
Dasatinib
Medicine
Internal medicine
Quality of life
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]